Dabrafenib CAS:1195765-45-7
Dabrafenib
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-3018 | 500mg | 500.00 | + Add to cart |
|
| R-C-3018 | 1g | 900.00 | + Add to cart |
|
| R-C-3018 | 2g | 1550.00 | + Add to cart |
|
|
|
||||
Product description
Dabrafenib, also known as GSK2118436 , is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene.Only for scientific research, not for human body.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| purity | >95% |
| Solubility | N/A |
| Cas | 1195765-45-7 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Dabrafenib
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


